DEA Schedules Four Ridiculous Synthetic Drug Names in Schedule I
Published Date: 5/1/2026
Rule
Summary
Starting May 1, 2026, the DEA officially puts four new substances—4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA—into Schedule I, meaning they’re now illegal to make, sell, or use without special permission. This affects anyone handling these chemicals, including researchers and businesses, who must follow strict rules or face serious penalties. The move aims to keep communities safer by cracking down on these risky drugs.
Analyzed Economic Effects
6 provisions identified: 1 benefits, 4 costs, 1 mixed.
Four Chemicals Placed in Schedule I
Starting May 1, 2026, DEA permanently places 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I. That means making, distributing, importing, exporting, or possessing these substances is unlawful without DEA authorization and persons who handle them face administrative, civil, and criminal sanctions.
Registration Required to Handle Substances
Any person who handles or wants to handle these four substances must register with DEA under 21 U.S.C. 822, 823, 957, and 958 and the implementing regulations. Persons who currently handle them and are not registered may not continue to handle them as of May 1, 2026.
Research Continuation Window and Hearing Timelines
If on May 1, 2026 you are registered to conduct research with another Schedule I substance, you may continue research on these four substances only if you submit a completed registration or modification application within 90 calendar days after May 1, 2026. If DEA serves an order to show cause proposing denial, you may request a hearing which will be held on an expedited basis and not later than 45 calendar days after the request unless you ask for a later date.
Compliance Rules: Security, Inventory, and Reporting
Registered handlers must follow Schedule I controls: meet security requirements, complete initial inventories on the date they first handle these substances, take inventories every two years, comply with labeling and packaging rules, submit required records and reports (including to the Automation of Reports and Consolidated Order System), and use required order forms for distribution.
Disposal Requirement for Unregistered Holders
If you are unwilling or unable to obtain a Schedule I registration, you must surrender or transfer all quantities you hold of these substances to a DEA-registered person before the effective date (May 1, 2026) and dispose of them in accordance with 21 CFR part 1317 and applicable laws.
DEA Certifies Little Small-Entity Economic Impact
DEA states, under the Regulatory Flexibility Act, that this final rule will not have a significant economic impact on a substantial number of small entities.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-13364 — Schedules of Controlled Substances: Temporary Placement of 5,6- Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
Starting July 1, 2026, the DEA is temporarily putting four new substances—5,6-dichloro brorphine, 5,6-dichloro desmethylchlorphine, N-propionitrile chlorphine, and spirochlorphine—into Schedule I, the strictest drug category. This means anyone making, selling, or using these chemicals will face tough legal rules and penalties. The move helps keep these potentially dangerous drugs off the streets while the DEA studies them further.
2026-13145 — Importer of Controlled Substances Application: Almac Clinical Services Incorp. (ACSI)
Almac Clinical Services Incorp. (ACSI) wants to become an official importer of certain controlled substances, including psilocybin and oxycodone. This affects drug manufacturers and others in the industry who can comment or request a hearing by July 30, 2026. No direct costs are mentioned, but the decision could impact how these substances enter the U.S. market.
2026-13144 — Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC
Catalent Pharma Solutions wants to become an official importer of some powerful controlled substances like LSD and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by July 30, 2026. This move could impact companies involved in these substances and the government’s control over them.
2026-12653 — Schedules of Controlled Substances: Placement of Bromazolam in Schedule I; Correction
The DEA fixed a typo in the official chemical name of bromazolam, a drug they put in the strictest Schedule I category starting March 16, 2026. This correction makes the rules clear for everyone involved, especially law enforcement and drug handlers. No new fees or deadlines, just a clean-up to keep things accurate and official.
Previous / Next Documents
Previous: 2026-08515 — Overweight and Oversize Items Fee Application
Starting July 12, 2026, the Postal Service will charge a $200 fee for overweight or oversize items found in the mail system or reported in shipping manifests. This fee applies to both retail and commercial mailers, except for items caught and returned during retail transactions. Mailers must pay the fee before their item is released, so watch your package size and weight!
Next: 2026-08533 — Pacific Halibut Fisheries of the West Coast; 2026 Catch Sharing Plan and Recreational Fishery Management Measures
Starting April 30, 2026, new rules will change how Pacific halibut fishing works off Washington, Oregon, and California. These updates share the catch fairly and set fun fishing season dates to protect halibut while giving anglers more chances to reel them in. If you fish recreationally, get ready for new limits and areas to keep the halibut population healthy and the fishing exciting!